The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Leptin Induces Hypertrophy via Endothelin-1–Reactive Oxygen Species Pathway in Cultured Neonatal Rat Cardiomyocytes
Abstract
Background— Obesity is a major risk factor for the development of cardiovascular disease. Emerging evidence indicates that leptin, a protein encoded by the obesity gene, is linked with cardiac hypertrophy in obese humans and directly induces cardiomyocyte hypertrophy in vitro. However, the mechanisms by which leptin induces cardiomyocyte hypertrophy are poorly understood. Methods and Results— This study investigated how leptin contributes to cardiomyocyte hypertrophy. Cultured neonatal rat cardiomyocytes were used to evaluate the effects of leptin on hypertrophy. Both endothelin-1 (ET-1) and reactive oxygen species (ROS) levels were elevated in a concentration-dependent manner in cardiomyocytes treated with leptin for 4 hours compared with those cells without leptin treatment. ET-1 stimulated ROS production in a concentration-dependent manner in cardiomyocytes. The augmentation of ROS levels in cardiomyocytes treated with both leptin and ET-1 was reversed by a selective ET A receptor antagonist, ABT-627, and catalase, a hydrogen peroxide–decomposing enzyme. After treatment for 72 hours, leptin or ET-1 concentration-dependently increased total RNA levels, cell surface areas, and protein synthesis in cardiomyocytes, all of which were significantly inhibited by ABT-627 or catalase treatment. Conclusions— These findings indicate that leptin elevates ET-1 and ROS levels, resulting in hypertrophy of cultured neonatal rat cardiac myocytes. The ET-1–ET A –ROS pathway may be involved in cardiomyocyte hypertrophy induced by leptin. ET A receptor antagonists and antioxidant therapy may provide an effective means of ameliorating cardiac dysfunction in obese humans.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Leptin can also induce generation of reactive oxygen species in the heart (379).”
From Cardiac remodeling in obesity (2008) · cites this paper as [379]
In the citing paper
“Several reports have suggested that leptin directly induced hypertrophy in both human and rodent cardiomyocytes (217, 292, 293, 379).”
From Cardiac remodeling in obesity (2008) · cites this paper as [379]
Citations
Cites
Cardiac Hypertrophy: The Good, the Bad, and the Ugly
Frey, N., & Olson, E. N. (2003) · Annual Review of Physiology · doi:10.1146/annurev.physiol.65.092101.142243 · Cited by 1,480
Keaney, J. F., Larson, M. G., Vasan, R. S., Wilson, P. W. F., Lipinska, I., Corey, D., Massaro, J. M., Sutherland, P., Vita, J. A., & Benjamin, E. J. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000058402.34138.11 · Cited by 1,304
Tartaglia, L. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.10.6093 · Cited by 1,289
Ziccardi, P., Nappo, F., Giugliano, G., Esposito, K., Marfella, R., Cioffi, M., D’Andrea, F., Molinari, A. M., & Giugliano, D. (2002) · Circulation · doi:10.1161/hc0702.104279 · Cited by 994
The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus
Finck, B. N., Lehman, J. J., Leone, T. C., Welch, M. J., Bennett, M. J., Kovács, A. D., Han, X., Gross, R. W., Kozak, R., Lopaschuk, G. D., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14080 · Cited by 887
Unger, R. H. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.104057 · Cited by 875
Wallace, A. M., McMahon, A. D., Packard, C. J., Kelly, A., Shepherd, J., Gaw, A., & Sattar, N. A. (2001) · Circulation · doi:10.1161/hc5001.101061 · Cited by 821
Cardiovascular Health in Childhood
Williams, C. L., Hayman, L. L., Daniels, S. R., Robinson, T. N., Steinberger, J., Paridon, S. M., & Bazzarre, T. L. (2002) · Circulation · doi:10.1161/01.cir.0000019555.61092.9e · Cited by 778
The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus
Finck, B. N., Lehman, J. J., Leone, T. C., Welch, M. J., Bennett, M. J., Kovács, A., Han, X., Gross, R. W., Kozak, R., Lopaschuk, G. D., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214080 · Cited by 765
Leptin induces oxidative stress in human endothelial cells
Bouloumié, A., Marumo, T., Lafontan, M., & Busse, R. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.10.1231 · Cited by 679
Cited by
Sorted by citations
Items 201–233 of 233
Постоева, А. В., & Dvoryashinva, I. V. (2015) · Obesity and metabolism · doi:10.14341/omet2015210-13 · Cited by 2
PLASMA LEPTIN LEVELS IN METABOLIC SYNDROME PATIENTS WITH ISCHEMIC HEART DISEASE
Drapkina, O. M., Шепель, Р. Н., & Deeva, Т. A. (2016) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2016-3-43-48 · Cited by 2
Fatouros, I. G., & Mitrakou, A. (2012) · CRC Press eBooks · doi:10.1201/b12085-16 · Cited by 2
Karmazyn, M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803111-7.00003-8 · Cited by 2
A new season of Chinese cardiovascular pharmacology research
Chen, A. F., & Su, D. (2005) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2005.00060.x · Cited by 2
Self-citationLeptin Signaling in the Cardiovascular System
Karmazyn, M., Purdham, D. M., Rajapurohitam, V., & Zeidan, A. (2008) · Springer eBooks · doi:10.1007/978-0-387-09552-3_20 · Cited by 2
Comparative effects of fatty acid and glucose in cardiac remodeling
Duttaroy, A. K., & Mallick, R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99570-2.00001-1 · Cited by 1
Cardiomyopathy in diabetics: a review of current opinion on the underlying pathological mechanisms
Ashrafi, R., & Davis, G. K. (2011) · Avances en Diabetología · doi:10.1016/j.avdiab.2011.08.002 · Cited by 1
Drapkina, O. M., Шепель, Р. Н., & Deeva, Т. A. (2018) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2018-14-1-27-33 · Cited by 1
Cingolani, H. E., Aiello, E. A., Pérez, N. G., Ennis, I. L., & de Hurtado, M. C. C. (2005) · Europe PMC (PubMed Central) · Cited by 1
Gajewska, J., Chełchowska, M., Ambroszkiewicz, J., Riahi, A., Weker, H., & Szamotulska, K. (2018) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0723-3951 · Cited by 1
ADIPOSE TISSUE AS AN ENDOCRINE ORGAN: PATHOPHYSIOLOGICAL AND THERAPEUTIC IMPLICATIONS
Pérez-Mayorga, M. (2007) · Redalyc (Universidad Autónoma del Estado de México) · Cited by 8
Endothelin Signaling in the Cardiomyocyte
Sugden, P. H., & Clerk, A. (2008) · Springer eBooks · doi:10.1007/978-1-84628-919-4_3
Modulation of the Cardiomyocyte Hypertrophic Responses to Endothelin-1 by Adipocytes
Bairwa, S. C. (2014) · Scholarship@Western (Western University)
O tratamento com leptina por 7 e 28 dias altera a função e a morfologia renal de ratos.
Thieme, K. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2014.tde-18112014-161417
Obesity and Cardiac Dysfunction
Sweeney, G., Litwin, S. E., & Abel, E. D. (2010) · Springer eBooks · doi:10.1007/978-1-4419-1607-5_14
Finch, J. (2016) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/2520
Biochemii, K., & Medyczny, U. (2012)
DIABETES AND OBESITY: EVIDENCE FOR A CARDIOMYOPATHY
Ashrafi, R. (2016) · University of Liverpool · doi:10.17638/03003030
Análise do microRNA-22 na hipertrofia cardíaca induzida pela dieta hiperlipídica.
Guedes, E. C. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.42.2016.tde-08082016-084757
Leptin and Obesity: Role in Cardiac Structure and Dysfunction
Zibadi, S., Larson, D. F., & WATSON, R. R. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-571-2_12
Adipocinas e lesões de órgãos-alvo na hipertensão arterial resistente
Sabbatini, A. R. (2013) · doi:10.47749/t/unicamp.2013.909251
Savitsky, I. V., Tsypoviaz, S. V., Zashchuk, R. G., Lenik, R. G., & Znamerovsky, S. G. (2022) · Perioperaciina Medicina · doi:10.31636/prmd.v5i1.6
Sirman, Y. V., Прейс, Н. І., & Savytskyi, І. V. (2021) · Journal of Education Health and Sport · doi:10.12775/jehs.2021.11.10.038
Cell Signaling Mechanisms Underlying the Cardiac Actions of Adipokines
Karmazyn, M., & Rajapurohitam, V. (2011) · Royal Society of Chemistry eBooks · doi:10.1039/9781849733434-00057
Metabolic Syndrome-Induced Cardiac Fibrosis
Zibadi, S. (2009) · UA Campus Repository (The University of Arizona)
Thymoquinone Protects Against Cardiac Hypertrophy via PPAR ‐γ/ PI3K /Akt Pathway
Qiu, R., Wu, Z., Xu, Z., Hu, L.-J., Zhao, S.-T., Zeng, R., Qiu, Z.-C., Zhou, L., Lai, S., Wang, W., et al. (2026) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70911
Khine, H. E. E., Mangmool, S., & Parichatikanond, W. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118027
Metadata
- Authors
- Xu, F.-P., Chen, M.-S., Wang, Y.-Z., Yi, Q., Lin, S.-B., Chen, A. F., & Luo, J.-D.
- Affiliations
- From the Departments of Pharmacology (F.-P.X., Q.Y., S.-B.L., J.-D.L.) and Internal Medicine (M.-S.C.), Guangzhou Medical College, Guangzhou, China; the Department of Research Laboratory of Pathophysiology, PLA General Hospital, Beijing (Y.-Z.W.), China; and Department of Pharmacology and Toxicology and the Neuroscience Program, Michigan State University, East Lansing, Mich (A.F.C., J.-D.L.). Dr Xu is now at the Department of Pathology, Preclinical Medicine School, Sun Yat-sen University, Guangzhou...
- Sun Yat-sen University (CN)
- ORCID
- Chen, Alex F.
- Venue
- Circulation
- Published
- 2004-09-07
- Volume
- 110
- Issue
- 10
- Pages
- 1269-1275
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2004341742
- Cited by
- 234
- References
- 44
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 6 · 2023: 7 · 2022: 6 · 2021: 8 · 2020: 12 · 2019: 5 · 2018: 6 · 2017: 6 · 2016: 7 · 2015: 9 · 2014: 8 · 2013: 6 · 2012: 13
- FWCI
- 14.92
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- leptin, cardiac hypertrophy, endothelin-1, reactive oxygen species, ETA receptor, atrasentan, catalase, neonatal rat cardiomyocytes, obesity, antioxidant therapy, obesity-related cardiovascular disease
- MeSH terms
- Atrasentan, Animals, Animals, Newborn, Antioxidants, Catalase, Cells, Cultured, Gene Expression Regulation, Cardiomegaly, Atrial Natriuretic Factor, Obesity, Pyrrolidines, RNA, Messenger, Rats, Sprague-Dawley, Reactive Oxygen Species, Oxidative Stress, Endothelin-1, Reverse Transcriptase Polymerase Chain Reaction, Leptin, Myocytes, Cardiac, Cell Size, Rats, Endothelin A Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
